MedWorm: Marketing

Some Say New York City Health Ads Should Inspire, Not Scare

NYT — Mon, 06 Feb 2012 19:10:06 +0100

The city health department’s campaign to jolt New Yorkers out of their bad habits has drawn some criticism for its negative approach. (Source: NYT)

MedWorm Sponsor Message: Find the best January Sales in the UK.

In latest vaccine marketing fraud, CDC says Gardasil shots should be 'routine' for boys

NaturalNews.com — Mon, 06 Feb 2012 06:00:00 +0100

Every male between the ages of 11 and 21 should get a Gardasil vaccine for cervical cancer, and those between the ages of 13 and 21 should also get "catch-up" shots later down the road. This is only the opinion of the U.S. Centers for Disease Control and Prevention's... (Source: NaturalNews.com)

6 Ways to Start Your Own Brand

Psychology Today Work Center — Fri, 03 Feb 2012 18:10:31 +0100

Thinking about creating your own brand? It's got to start somewhere. Here are six tips to get the ball rolling. read more (Source: Psychology Today Work Center)

Advertising bans - Motta M.

SafetyLit: All (Unduplicated) — Fri, 03 Feb 2012 12:18:19 +0100

I show that an advertising ban is more likely to increase--rather than decrease--total consumption when advertising does not bring about a large expansion of market demand at given prices and when it increases product differentiation (thus allowing firms t... (Source: SafetyLit: All (Unduplicated))

Caris Diagnostics Announces Name Change to Miraca Life Sciences

Medical News (via PRIMEZONE) — Fri, 03 Feb 2012 07:00:00 +0100

TOKYO and IRVING, Texas, Feb. 3, 2012 (GLOBE NEWSWIRE) -- Caris Diagnostics, specializing in academic-caliber anatomic pathology services, today announced a company name change to Miraca Life Sciences following its November 2011 acquisition by Tokyo-based Miraca Holdings Inc., Japan's largest clinical diagnostics and laboratory testing service provider. The name change, which is effective February 20, 2012, follows a successful integration process and will be reflected in all marketing and communications. (Source: Medical News (via PRIMEZONE))

E-Cigarettes: Promise or Peril?

Nursing Clinics of North America — Fri, 03 Feb 2012 02:41:30 +0100

This article provides an overview of the history, production, and marketing of e-cigarettes, the contents of e-cigarettes and vapor, how they are used, public health concerns, and implications for nursing practice, research, and policy development. (Source: Nursing Clinics of North America)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Allergan halts Lap-Band sales to 1-800-GET-THIN clinics

Los Angeles Times - Science — Fri, 03 Feb 2012 02:26:00 +0100

Lap-Band's maker, Allergan, will no longer sell the device to facilities affiliated with the marketing campaign.The maker of the Lap-Band will no longer sell its product to clinics affiliated with the 1-800-GET-THIN marketing company — a blow to Southern California surgery centers that have built an empire implanting the weight-loss devices in people looking to shed pounds. (Source: Los Angeles Times - Science)

Drug firm Indoco Remedies ties up with DSM pharma

The Economic Times Healthcare and Biotech News — Thu, 02 Feb 2012 23:49:47 +0100

Drug firm Indoco Remedies has entered into a marketing pact with DSM Pharmaceutical Products NV which will sell its products in Austria and other int'l mkts. (Source: The Economic Times Healthcare and Biotech News)

Prescriptions Blog: Drug Makers Dial Down TV Advertising

NYT Health — Thu, 02 Feb 2012 23:27:05 +0100

Pharmaceutical companies have cut spending on television advertising by 20 percent over the last five years, according to a Nielsen study. Analysts expect drug advertising to continue to fall as more brand-name drugs face generic competition. (Source: NYT Health)

Survey: 75 percent of Americans admit to using phone while in bathroom

Health News: CBSNews.com — Thu, 02 Feb 2012 21:35:52 +0100

Marketing company 11Mark asked 1,000 Americans about their bathroom and mobile phone habits (Source: Health News: CBSNews.com)

5 issues affecting cloud service quality and performance

Healthcare IT News — Thu, 02 Feb 2012 20:54:03 +0100

As the industry is slowly changing the way it serves patients, cloud computing has become a way to reduce costs, improve services and simplify management. But with the growing use of cloud service come concerns about its performance and overall quality, said Daniel Joseph Barry, vice president of marketing at Napatech. read more (Source: Healthcare IT News)

MedWorm Sponsor Message: Find the best January Sales in the UK.

The suspension of marketing authorisations for meprobamate-containing drugs in Europe

Reactions — Thu, 02 Feb 2012 18:34:27 +0100

(Source: Reactions)

Pharmacists say marketing of Medicare drug plans is misleading

American Medical News — Thu, 02 Feb 2012 12:59:50 +0100

A community pharmacy association has asked the Centers for Medicare & Medicaid Services to allow disgruntled patients to switch Part D plans midyear. (Source: American Medical News)

Spectranetics Announces Interim Results from German Study Treating Patients with Peripheral In-Stent Restenosis

HSMN NewsFeed — Thu, 02 Feb 2012 12:59:10 +0100

Results Provide Basis for Landmark EXCITE ISR Trial Underway in United States COLORADO SPRINGS, Colo.--(Healthcare Sales & Marketing Network)-- Spectranetics Corporation (Nasdaq:SPNC ) today announced six month interim results from the PATENT (Photo-Abl... Devices, InterventionalSpectranetics, PATENT study, peripheral in-stent restenosis, laser atherectomy (Source: HSMN NewsFeed)

Uganda: UHMG Pushes for Smaller Families

AllAfrica News: Pregnancy and Childbirth — Thu, 02 Feb 2012 08:09:05 +0100

[EA Business] In a bid to mitigate this problem, Uganda Health Marketing Group (UHMG) in partnership with USAID last week launched a three day campaign -"Genext" to educate and "breed" a generation of young men and women to have small manageable families. (Source: AllAfrica News: Pregnancy and Childbirth)

Advertising: Orthodontists Market to Adults Seeking Prettier Smiles

NYT Health — Thu, 02 Feb 2012 02:47:27 +0100

The American Association of Orthodontists has been running ads aimed at the rising number of adults seeking braces or teeth-straightening services. (Source: NYT Health)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Vascular Solutions Launches Reprocessing Service for ClosureFAST(R) Vein Catheters

Medical News (via PRIMEZONE) — Wed, 01 Feb 2012 21:05:00 +0100

MINNEAPOLIS, Feb. 1, 2012 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it is marketing a reprocessing service for the ClosureFAST radiofrequency ablation catheter in the United States. The ClosureFAST catheter, which is manufactured and marketed by VNUS Medical Technologies, Inc. division of Covidien, is widely used for performing endovenous therapy for the treatment of varicose veins. Vascular Solutions' reprocessing service is designed to help physicians reduce medical waste and lower their costs. (Source: Medical News (via PRIMEZONE))

D&R Acquires LATHIAN to Create Leading Multichannel Marketing Agency

Drugs.com - Pharma News — Wed, 01 Feb 2012 14:50:23 +0100

New Combined Entity Delivers Strategic Multichannel Marketing Services Under One Roof for Pharmaceutical Companies to Increase Brand Performance at Any Stage of their Product Lifecycle SHREWSBURY, N.J. & LAKE FOREST, Calif.--(BUSINESS... (Source: Drugs.com - Pharma News)

UCB and Astellas Announce Agreement to Jointly Develop and Commercialize Cimzia (Certolizumab Pegol) in Japan

Drugs.com - Pharma News — Wed, 01 Feb 2012 12:10:11 +0100

Astellas and UCB partner to bring certolizumab pegol to rheumatoid arthritis patients in Japan UCB files certolizumab pegol for marketing authorisation with the Japanese Ministry of Health, Labour and Welfare Tokyo, Japan and Brussels, Belgium, 1st... (Source: Drugs.com - Pharma News)

EXTRA STRENGTH HEADACHE RELIEF (Acetaminophen, Aspirin And Caffeine) Tablet, Film Coated [CHAIN DRUG MARKETING ASSOCIATION INC]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Wed, 01 Feb 2012 05:00:00 +0100

Updated Date: Feb 1, 2012 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Asian medicine: Call for more safety data

Nature — Wed, 01 Feb 2012 05:00:00 +0100

Authors: Juncai Xu, Min Liu & Zhijie Xia Marketing of traditional Chinese medicines is developing rapidly worldwide (Nature480, S81–S103; 2011). So much so that the European Union (EU) issued a directive in 2004 that all herbal preparations should be subject to the same screening procedures as (Source: Nature)

MedWorm Sponsor Message: Find the best January Sales in the UK.

DSM Announces Marketing And Sales Alliance With Indoco

Pharmaceutical Online News — Tue, 31 Jan 2012 10:26:00 +0100

Royal DSM N.V., recently announced the signing of an agreement with Indoco Remedies Limited, Mumbai, India, for commercial cooperation for eight Active Pharmaceutical Ingredients (APIs). The alliance came into effect in January 2012. (Source: Pharmaceutical Online News)

Health at Every Size Is Anti-Dieting

Psychology Today Food and Diet Center — Mon, 30 Jan 2012 23:45:31 +0100

Poretsky explains: “If you love your body, you don't need diets or lap bands or botox or weight loss drugs. If you love your body, you're less likely to accept ill treatment, discrimination, bad medical care, etc. We have huge industries like the diet, pharmaceutical, beauty, marketing industries that literally bank on our self-hatred to sell products.” read more (Source: Psychology Today Food and Diet Center)

Cell Therapeutics withdraws cancer drug application

Reuters: Health — Mon, 30 Jan 2012 11:52:10 +0100

(Reuters) - Cell Therapeutics Inc said on Monday it has voluntarily withdrawn the marketing application for its cancer drug, sending its shares down 17 percent before the bell. (Source: Reuters: Health)

Royal Pharmaceuticals to Build a Branded Division

PRWeb: Medical Pharmaceuticals — Mon, 30 Jan 2012 07:31:07 +0100

Royal Pharmaceuticals, a division of Granard Pharmaceutical Sales & Marketing, announces plans to build a commercial branded pharmaceutical division in 2012.(PRWeb January 27, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9141693.htm (Source: PRWeb: Medical Pharmaceuticals)

Are we victims of aggressive marketing?

American Journal of Orthodontics and Dentofacial Orthopedics — Sun, 29 Jan 2012 16:46:13 +0100

The thought-provoking column by Dr Peter Greco in the November issue of the AJO-DO couldn’t have been better timed! It had us trying to reflect on the few decennia of advancements and innovations in orthodontics that have helped define our specialty as it is today. On a clinical note, although these innovations might undoubtedly have revolutionized the way we practice orthodontics (in terms of increased efficiency and productivity), they have also taken some of the excitement (patient-personalized wire-bending) from our specialty by a great degree. (Source: American Journal of Orthodontics and Dentofacial Orthopedics)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Doctor and Patient: Doctor and Patient: Using Symptom Checklists to Sell Drugs

NYT Health — Fri, 27 Jan 2012 15:13:15 +0100

Checklists of symptoms have become a critical part of every major pharmaceutical marketing campaign, making it easy for patients to diagnose their own ailments -- and making it easy for drug makers to sell drugs. (Source: NYT Health)

Aceto Corporation Schedules Fiscal 2012 Second Quarter Financial Results News Release and Conference Call

Medical News (via PRIMEZONE) — Fri, 27 Jan 2012 11:55:00 +0100

PORT WASHINGTON, N.Y., Jan. 27, 2012 (GLOBE NEWSWIRE) -- Aceto Corporation (Nasdaq:ACET), a global leader in the marketing and distribution of pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products and specialty chemicals, today announced that it will issue its financial results of operations for its 2012 fiscal second quarter ended December 31, 2011 after the stock market closes on Thursday February 9, 2012. On Friday February 10, 2011, at 9:00 am ET, Albert Eilender, Ronald Gold and Douglas Roth will conduct a conference call. (Source: Medical News (via PRIMEZONE))

To Be or Not to Be Price Conscious—a Segment‐Based Analysis of Compromise Effects in Market‐Like Framings

Psychology and Marketing — Fri, 27 Jan 2012 07:36:17 +0100

This article reports two consecutively implemented studies demonstrating that the compromise effect is robust even in an enhanced design that incorporates basic conditions of real purchase decisions in laboratory‐based experiments. Specifically, the relative share of the middle option increases significantly in an overall analysis when experienced consumers make unforced decisions between real brands in a binding choice context. However, segmented analysis indicates substantial differences, meaning that (1) the compromise effect is strong and significant among quality‐seeking consumers, whereas (2) the compromise effect is weak and insignificant among price‐conscious subjects. (Source: Psychology and Marketing)

Adolescent Evaluations of Brand Extensions: The Influence of Reference Group

Psychology and Marketing — Fri, 27 Jan 2012 07:36:16 +0100

This study examines the reference group effect on adolescent evaluations of brand extension. Three factors are important to this process: the product fit between parent and extension category (similar vs. dissimilar), the consumption type of the extension product (public vs. private), and the parent brand image (prestige‐oriented vs. functional‐oriented). An experiment with 217 teenagers generally supports the hypotheses. Results suggest that adolescents are willing to pay a higher price premium to publicly consumed brand extension product than a privately consumed. In addition, the level of category similarity enhances the consumption type effect. Managerial implications on brand extension strategy in adolescent's market are discussed. (Source: Psychology and Marketing)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Does Friendship Help in Personal Selling? The Contingent Effect of Outcome Favorability

Psychology and Marketing — Fri, 27 Jan 2012 07:36:15 +0100

ABSTRACTAlthough widespread belief holds that salespeople can leverage their personal relationships with prospective customers to gain business, previous research has not investigated the implications of friendships between salespeople and customers for customers’ postpurchase satisfaction and fairness judgment. Findings from two experiments show that friendships benefit salespeople only when the outcome of the transaction is unfavorable. Specifically, when salespeople and customers are close friends rather than acquaintances, the customers perceive an unfavorable outcome as relatively more fair and satisfactory, but such an effect does not occur when the outcome of the transaction is favorable. This paper also shows that customers’ perceived fairness mediates the interaction effect be...

Customer Satisfaction and Elapsed Time since Purchase as Drivers of Price Knowledge

Psychology and Marketing — Fri, 27 Jan 2012 07:36:13 +0100

This study investigates the influence of customer satisfaction and elapsed time since purchase on customers’ explicit and implicit knowledge of price. The results of two large, independent surveys of customers who purchased a consumer durable good indicate that customer satisfaction and elapsed time have different effects on explicit versus implicit price knowledge. Customer satisfaction has a negative impact on explicit price knowledge, but no substantial effect on implicit price knowledge. The length of time between purchase and retrieval of the price information has a negative impact on explicit price knowledge but no substantial effect on implicit price knowledge. Finally, customer satisfaction has a moderating role, in that the higher the customer satisfaction level, the stronger th...

Consumer Behavior in Later Life: Current Knowledge, Issues, and New Directions for Research

Psychology and Marketing — Fri, 27 Jan 2012 07:36:12 +0100

This article advocates the value of emergent paradigms and methods that are becoming increasingly popular in behavioral sciences and hold promise for studying the consumer behavior of older adults. It particularly recommends approaches that emphasize the importance of examining consumers in the context of the time and life circumstances in which they are embedded, and it builds a research agenda to help address contemporary research issues and guide further research. (Source: Psychology and Marketing)

HealthyCircles’ First Webinar of 2012- Population Health Management:...

PRWeb: Medical Pharmaceuticals — Fri, 27 Jan 2012 06:33:34 +0100

Dr. Susan Nedza, MBA, FACEP and Vice President of Strategic Clinical Solutions at HealthyCircles, along with special guest Adam Pellegrini, Director of Marketing and Online Strategy at HealthyCircles,...(PRWeb January 25, 2012)Read the full story at http://www.prweb.com/releases/EngagePatients/HealthyCircles/prweb9130205.htm (Source: PRWeb: Medical Pharmaceuticals)

Budco Expands East Coast Digital Print Capability

PRWeb: Medical Pharmaceuticals — Fri, 27 Jan 2012 06:33:34 +0100

Budco, a leading fulfillment and direct marketing organization, announced today that it has expanded their New Jersey-based print and fulfillment center through the addition of a third Xerox iGen...(PRWeb January 25, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9131107.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Interim Co-lead Counsel Named For Plaintiffs In Multidistrict Imprelis Suits

LexisNexis® Mealey's™ Emerging Toxic Torts Legal News — Fri, 27 Jan 2012 00:37:13 +0100

PHILADELPHIA - The U.S. District Court for the Eastern District of Pennsylvania judge presiding over the multidistrict Imprelis products liability litigation named interim co-lead counsel for the plaintiffs in an order entered Jan. 11 (In re: Imprelis Herbicide Marketing, Sales Practices & Products Liability Litigation, No. 11-2284, MDL 2284, E.D. Pa.; See 11/01/11, Page 9). Full story on lexis.com (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)

How To Tell Your Small Business Story

Psychology Today Work Center — Thu, 26 Jan 2012 23:46:59 +0100

I recently gave a talk to a group of new authors on how to promote and market their books. Instead of taking the time and expense of providing handouts (not to mention all the trees saved), I decided to create a SlideShare presentation and offer it, post-conference, to the participants.read more (Source: Psychology Today Work Center)

Will sitting close to the TV hurt my kids’ eyes?

Thrive, Children's Hospital Boston — Thu, 26 Jan 2012 21:30:51 +0100

Michael Rich, MD, MPH Michael Rich, MD, MPH, is Children’s Hospital Boston’s media expert and director of Children’s Center on Media and Child Health. Take a look at his blog archive or follow him on Twitter @CMCH_Boston Q: I have an son who’s 11 and a daughter who’s 9½, and for many years, they have sat close to the TV when watching. I have asked them to sit farther away, and they do move back maybe a foot…but they always go back to viewing the show close up, even if the screen is a 40” color flat screen. Any studies that show why? Any concerns? My wife and I sit 8 to 10 feet from the TV. -Up Close and Personal, in Rochester Hills, MI A: Dear Up Close, Concern about sitting close to TV screens, like concern about reading in low light, is founded more on what our parents to...

Charter Medical Receives CE Mark Clearance for Next Generation Cell Freeze(R) Cryogenic Stem Cell Storage Containers

Medical News (via PRIMEZONE) — Thu, 26 Jan 2012 21:05:00 +0100

MANCHESTER, Conn., Jan. 26, 2012 (GLOBE NEWSWIRE) -- Charter Medical, Ltd., a Lydall subsidiary, (NYSE:LDL) announced today that it received CE Mark approval on its next generation Cell Freeze(r) Cryogenic Storage Containers for Hematopoietic Progenitor Cells (HPC's). The issuance of the approval by European regulators allows Charter Medical to begin marketing and selling the newly designed and expanded product offering for cryogenic storage, preservation, and transfer of HPC's in Europe. These next generation storage containers offer a broad size range from 50 mL to 750 mL and have excellent durability when frozen at ultralow (-196*C) temperatures. (Source: Medical News (via PRIMEZONE))

Consumer Spending and Customer Satisfaction: Untying the Knot

Advances in Pharmacological Sciences — Thu, 26 Jan 2012 18:56:20 +0100

The recession of 2007–2009 has led to renewed interest in forecasting discretionary consumer spending and whether marketing variables contain predictive content. Using the ACSI customer satisfaction index and both linear and nonlinear methods, this note suggests the index fails to enhance our understanding of the temporal evolution of discretionary spending. (Source: Advances in Pharmacological Sciences)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Well Blog: Using Symptom Checklists to Sell Drugs

NYT Health — Thu, 26 Jan 2012 17:18:36 +0100

Doctor and Patient: Using Symptom Checklists to Sell Drugs

NYT Health — Thu, 26 Jan 2012 17:18:36 +0100

Is There a Cure for Mediocre Pharma Mobile Apps?

Pharma Marketing News — Thu, 26 Jan 2012 15:44:34 +0100

Listen Up, New Marketing Grads! Mobile is the new 'shiny thing' of interest to pharmaceutical marketers. However, most pharma mobile apps that I have seen are pretty mundane as far as marketing/advertising is concerned. What's it going to take to make these apps more interesting and useful? (Source: Pharma Marketing News)

Novo Nordisk Defends Choice of Paula Deen as Diabetes Spokesperson

Pharma Marketing News — Thu, 26 Jan 2012 15:44:09 +0100

Unless you are living under a rock on the Moon, you've probably heard that Novo Nordisk has teamed up with celebrity Southern-style chef Paula Deen as a paid spokesperson. Ambre Morley, Associate Director, Product Communications, Novo Nordisk, answers questions about why her company teamed up with Deen as a diabetes spokesperson. (Source: Pharma Marketing News)

FDA Social Media Guidelines May Be Moot

Pharma Marketing News — Thu, 26 Jan 2012 15:43:45 +0100

This article presents the relevant case information. (Source: Pharma Marketing News)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

FDA Guidance on Responding to Unsolicited Requests for Off-Label Information

Pharma Marketing News — Thu, 26 Jan 2012 15:42:44 +0100

This article takes a closer look at how the off-label guidelines apply to social media such as Youtube, Blogs, and Twitter. (Source: Pharma Marketing News)

DAY CREAM REPLENISHING HYDRATOR SPF 25 (Octinoxate Avobenzone) Lotion [MOSAIC MARKETING PARTNERS LLC]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Thu, 26 Jan 2012 05:00:00 +0100

Updated Date: Jan 26, 2012 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Mobile Marketing Association spells out privacy basics for app developers

mobihealthnews — Thu, 26 Jan 2012 00:23:45 +0100

The Mobile Marketing Association (MMA) is recommending that developers of mobile applications be as transparent as possible with their privacy and security policies to cut down on ambiguity and engender consumer trust. In a guidance document released Wednesday, the trade group outlines best practices for creating privacy policies and offers sample language that software companies can [...] (Source: mobihealthnews)

Federal Injunction Blocks Ranbaxy from Marketing in U.S.

MedPage Today Public Health — Wed, 25 Jan 2012 22:44:06 +0100

WASHINGTON --The Justice Department filed a consent decree today preventing generic drug giant Ranbaxy from selling drugs made at four of its manufacturing plants until it brings them into compliance with the FDA's quality standards. (Source: MedPage Today Public Health)

Démarrage du Programme “DMP en Région” le 13 Janvier 2012

ICMCC: The International Council on Medical and Care Compunetics — Wed, 25 Jan 2012 11:18:06 +0100

Source: Esante.gouv.fr Content: “Trois régions « Amorçage » ont apporté leur témoignage : retour d’expérience et approches marketing déployés en Alsace, Aquitaine et Picardie, pour accompagner les établissements et professionnels de santé au DMP. A cette occasion, l’ASIP Santé a également présenté les différents outils marketing mis à disposition : le CRM, les outils de [...] (Source: ICMCC: The International Council on Medical and Care Compunetics)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Are apps medical devices? Part two: Apps as medical devices – the regulatory framework

ICMCC: The International Council on Medical and Care Compunetics — Wed, 25 Jan 2012 09:21:08 +0100

Source: Paul Dixey and Sam Walmsley, pharmaphorum Content: “The main difference between how medicines and medical devices are regulated lies in how a product gets onto the market. In the UK all medicines are directly approved by the MHRA which issues a ‘marketing authorisation’, or licence. Medical devices however are approved by private sector organisations [...] (Source: ICMCC: The International Council on Medical and Care Compunetics)

In Health Dept. Ad, PhotoShop, Not Diabetes, Took Leg

NYT Health — Wed, 25 Jan 2012 05:21:39 +0100

A poster being put up in the subway system shows a man who lost his leg to diabetes. But he really didn’t. (Source: NYT Health)

FDA Clears 10-Minute Flu Test for MarketingFDA Clears 10-Minute Flu Test for Marketing

Medscape Medical News Headlines — Tue, 24 Jan 2012 21:27:49 +0100

Diagnostic devices maker Alere Inc said U.S. health regulators cleared its rapid influenza test for use in the country. FDA Approvals (Source: Medscape Medical News Headlines)

Risk management of biosimilars in oncology: each medicine is a work in progress

Targeted Oncology — Tue, 24 Jan 2012 18:15:17 +0100

Abstract Drug licensing and drug safety monitoring for standard chemical entities have been established and are routinely used. These have resulted in a solid foundation of knowledge from which confident therapeutic decisions can be made. For many chemical entities, this advanced level of experience is also present for the generic products. The expertise surrounding the development of biosimilar competitor versions is increasing and progress is encouraging. To address the re-engineering and comparability complexities of biosimilars, the European Union imposed a requirement that risk management plans be included in the medications’ marketing applications. This paper summarizes and discusses the circumstances complicating the public’s view of drug safety, historical inci...

Dia Marketing Of Pharmaceuticals 2012 Program Focuses On The Latest...

PRWeb: Medical Pharmaceuticals — Tue, 24 Jan 2012 06:18:59 +0100

Three-day Program, Geared Towards the Needs of your Entire Promotional Team(PRWeb January 23, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9128501.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

DAY CREAM MATTIFYING HYDRATOR SPF 25 (Octinoxate Avobenzone) Lotion [MOSAIC MARKETING PARTNERS LLC]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Tue, 24 Jan 2012 05:00:00 +0100

Updated Date: Jan 24, 2012 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

DAY CREAM REPLENISHING HYDRATOR SPF 25 (Octinoxate Avobenzone) Lotion [MOSAIC MARKETING PARTNERS LLC]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Tue, 24 Jan 2012 05:00:00 +0100

Updated Date: Jan 24, 2012 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

FDA clears Alere flu test for marketing

Reuters: Health — Mon, 23 Jan 2012 14:57:23 +0100

(Reuters) - Diagnostic devices maker Alere Inc said U.S. health regulators cleared its rapid influenza test for use in the country. (Source: Reuters: Health)

Ban Cosmetic Surgery Ads, Regulate The Industry, Urge To UK Government

Health News from Medical News Today — Mon, 23 Jan 2012 12:00:00 +0100

The British Association of Aesthetic Plastic Surgeons (BAAPS) is calling on the UK government to ban cosmetic surgery advertising and tighten up industry regulations, including carrying annual checks on surgeons. The association has long voiced its objection to the use of "marketing gimmicks" to promote cosmetic surgery and what it sees as the lax regulation of the industry. It says people acquire unrealistic expectations from exposure to reality shows and competitions that feature cosmetic surgery "makeovers" and "body overhauls"... (Source: Health News from Medical News Today)

FDA approves OTC handheld heart rhythm monitor

CMIO.net: The News Weekly for Health IT Executives — Mon, 23 Jan 2012 08:53:45 +0100

The FDA approved over-the-counter (OTC) sales and marketing of the HeartCheck Pen Handheld ECG, a handheld heart rhythm monitor manufactured by CardioComm Solutions. (Source: CMIO.net: The News Weekly for Health IT Executives)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Canola oil used to be called RAPESEED oil but the name was changed for marketing reasons

NaturalNews.com — Mon, 23 Jan 2012 06:00:00 +0100

Olive oil comes from olive, grapeseed oil comes from grape seeds, peanut oil comes from peanuts and canola oil comes from... (Source: NaturalNews.com)

FDA approves first test for risk of PML in patients taking natalizumab (Tysabri®)

NeLM - News — Mon, 23 Jan 2012 05:00:00 +0100

Source: FDA Area: News The US FDA has approved the marketing of the first test to help determine the risk of progressive multifocal leukoencephalopathy (PML) in people using natalizumab (Tysabri®) for the treatment of multiple sclerosis (MS) or Crohn's disease (CD). Testing positive for anti-JC virus (JCV) antibodies has been identified as a risk factor for PML. The Stratify JCV Antibody ELISA test helps to determine a patient's anti-JCV antibody status and can help healthcare providers determine the risk for developing PML, when used with other clinical data from the patient. The test has been analytically and clinically validated, and was cleared by FDA on January 20, 2012. The following risk factors have been found to increase the risk of developing P...

Pharma groups brace for costly settlements

FT.com - Drugs and Healthcare — Sun, 22 Jan 2012 16:06:40 +0100

Medical groups are concerned that they are being unfairly pursued by multiple investigators regarding alleged bribery and aggressive marketing practices (Source: FT.com - Drugs and Healthcare)

November Research Group Appoints Senior Bio-Pharmaceutical Industry...

PRWeb: Medical Pharmaceuticals — Sat, 21 Jan 2012 05:56:11 +0100

November Research Group, LLC, announces the appointment of bio-pharmaceutical industry veteran Susan A. Jalbert as Vice President of Sales and Marketing.(PRWeb January 19, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9116312.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Elizabeth Blackwell Would be Proud - 31 Percent of Physicians are...

PRWeb: Medical Pharmaceuticals — Sat, 21 Jan 2012 05:56:11 +0100

According to new analysis of American Medical Association Physician Masterfile data by Medical Marketing Service, Inc. (MMS), women now comprise 31% of physicians, up from just 12% in 1981. The...(PRWeb January 18, 2012)Read the full story at http://www.prweb.com/releases/2012/mms-women-physicians/prweb9112174.htm (Source: PRWeb: Medical Pharmaceuticals)

Dohmen Expands Healthcare Industry Position, Names Seasoned Marketing...

PRWeb: Medical Pharmaceuticals — Sat, 21 Jan 2012 05:56:11 +0100

The Dohmen Company today announced that Cynthia Frisina will assume the newly created position of Chief Marketing Officer. Frisina will guide branding initiatives and drive increased market share for...(PRWeb January 18, 2012)Read the full story at http://www.prweb.com/releases/Cynthia_Frisina/Dohmen/prweb9112567.htm (Source: PRWeb: Medical Pharmaceuticals)

House members call for probe into Lap-Band safety, marketing

Los Angeles Times - Science — Sat, 21 Jan 2012 01:57:00 +0100

Rep. Henry A. Waxman and two other House members want an investigation of the Lap-Band and the 1-800-GET-THIN campaign.Members of Congress are calling for an investigation into the 1-800-GET-THIN weight-loss surgery marketing campaign and the safety and effectiveness of the Lap-Band device. (Source: Los Angeles Times - Science)

Guided Therapeutics Provides Update on PMA Application for LuViva(R) Advanced Cervical Scan and Timing for Filing of CE Mark

HSMN NewsFeed — Fri, 20 Jan 2012 23:25:36 +0100

Company to Host Conference Call with Investors on January 23 at 10 A.M. EST NORCROSS, Ga.--(Healthcare Sales & Marketing Network)-- Guided Therapeutics, Inc. (OTCBB & OTCQB: GTHP) today announced that the company plans to seek an independent panel revie... Devices, Diagnostics, Oncology, FDA, RegulatoryGuided Therapeutics, LuViva, Advanced Cervical Scan, cervical cancer (Source: HSMN NewsFeed)

NovaDel Announces Termination of License Agreements for Ondansetron Oral Spray Product

HSMN NewsFeed — Fri, 20 Jan 2012 23:20:43 +0100

BRIDGEWATER, N.J.--(Healthcare Sales & Marketing Network)-- NovaDel Pharma Inc. (OTCBB: NVDL.OB ), a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced the termination of certain lice... Biopharmaceuticals, Drug Delivery, LicensingNovaDel Pharma, Talon Therapeutics, Par Pharmaceutical, ondansetron (Source: HSMN NewsFeed)

MedWorm Sponsor Message: Find the best January Sales in the UK.

FDA permits marketing of first test for risk of rare brain infection in some people treated with Tysabri

Food and Drug Administration — Fri, 20 Jan 2012 20:21:00 +0100

Today, the U.S. Food and Drug Administration allowed marketing of the first test to help determine the risk for a rare brain infection called progressive multifocal leukoencephalopathy (PML) in people using the drug Tysabri (natalizumab) to treat multiple sclerosis (MS) or Crohn’s disease (CD). (Source: Food and Drug Administration)

Professional Societies and Commercial Conflicts of Interest: Critics Blast Circuslike Atmosphere, Barker Marketing at Conferences

Annals of Emergency Medicine — Fri, 20 Jan 2012 19:16:32 +0100

Practicing a learned profession within a commercial culture has never been simple. The overlapping status of medicine in the United States as both a vocation and a business means that the borderlines of ethics and self-interest are constantly being drawn and redrawn. Medical professional organizations, like physicians, need to balance their healing mission and their cash flow. To an increasingly visible community of observers, many of these groups have lost this balance, even to the point of forfeiting the credibility as an independent professional authority. (Source: Annals of Emergency Medicine)

Remicade(R) (Infliximab) Receives Positive Opinion From CHMP In Europe for Treatment of Ulcerative Colitis in Pediatric Patients

HSMN NewsFeed — Fri, 20 Jan 2012 17:04:57 +0100

Positive Opinion Recommends Approval of the First and Only Anti-TNF Therapy in Pediatric Patients with Severely Active Ulcerative Colitis, a Chronic, Inflammatory Bowel Disease WHITEHOUSE STATION, N.J.--(Healthcare Sales & Marketing Network)-- MSD (also... Biopharmaceuticals, Gastroenterology, RegulatoryMerck, REMICADE, infliximab, ulcerative colitis (Source: HSMN NewsFeed)

Onglyza (saxagliptan)- Revised SPC

NeLM - SPC Changes — Fri, 20 Jan 2012 05:00:00 +0100

Source: eMC (electronic Medicines Compendium) Area: Other Library Updates > SPC Changes There have been significant updates to several sections of the SPC, including the following: Changes to section 4.4- Special warnings and precaution for use Pancreatitis In post-marketing experience there have been spontaneously reported adverse reactions of acute pancreatitis. Patients should be informed of the characteristic symptom of acute pancreatitis: persistent, severe abdominal pain. Resolution of pancreatitis has been observed after discontinuation of saxagliptin. If pancreatitis is suspected, Onglyza and other potentially suspect medicinal products should be discontinued. Please refer to SPC link below for full information o...

Colofac MR (Mebeverine)- Revised SPC

NeLM - SPC Changes — Fri, 20 Jan 2012 05:00:00 +0100

Source: eMC (electronic Medicines Compendium) Area: Other Library Updates > SPC Changes There have been significant updates to several sections of the SPC, including the following: Change to section 4.2- Posology and method of administration No posology studies in elderly, renal and/or hepatic impaired patients have been performed. No specific risk for elderly, renal and/or hepatic impaired patients could be identified from available post-marketing data. No dosage adjustment is deemed necessary in elderly, renal and/or hepatic impaired patients. Please refer to SPC link below for full information on all changes (Source: NeLM - SPC Changes)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

EMA recommends suspension of marketing authorisations for meprobamate-containing medicines in the EU

NeLM - News — Fri, 20 Jan 2012 05:00:00 +0100

Source: EMA Area: News The European Medicines Agency (EMA) has recommended the suspension of all marketing authorisations for oral medicines containing meprobamate, a sedative used to treat symptoms of anxiety and related conditions, including anxiety states, alcohol withdrawal, migraine attacks, digestive disorders, muscle tension or cramps, and insomnia. The decision was taken because the risks of these medicines, particularly of serious CNS adverse effects, are greater than their benefits. To ensure prescribers have enough time to determine the most appropriate treatments for patients, the withdrawal from the market will be carried out gradually, within 15 months of the decision. Doctors should consider alternative treatments in line with national recommendations for the con...

European CHMP recommends refusal of marketing authorisation for pralatrexate (Folotyn)

NeLM - News — Fri, 20 Jan 2012 05:00:00 +0100

Source: EMA Area: News The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion, recommending the refusal of the marketing authorisation for pralatrexate (Folotyn), intended for the treatment of peripheral T-cell lymphoma. The Committee was concerned that the main study was designed in a way that did not allow the assessment of benefit, particularly since the drug was not compared with any other treatment or placebo. Moreover, the study only assessed response to treatment so impact on progression free- or overall-survival is not known. Therefore the Committee concluded that the medicine's benefits did not outweigh its risks. (Source: NeLM - News)

Johnson & Johnson Settles Risperdal Claim in Texas

NYT Health — Fri, 20 Jan 2012 02:34:40 +0100

Johnson & Johnson said it would pay $158 million to end a lawsuit that accused it of inappropriately marketing its Risperdal antipsychotic drug to Texas residents on Medicaid. (Source: NYT Health)

Natalizumab (Tysabri) label change

Multiple Sclerosis Trust — Fri, 20 Jan 2012 00:00:00 +0100

The American FDA has approved a label change that will allow mention of the JC virus as a risk factor for PML (a side effect of natalizumab) and has approved the marketing of the STRATIFY test which shows exposure to the virus. Includes January's PML figures - 201 cases, 42 deaths out of more than 96,500 people treated. Med Page Today Biogen press release FDA safety announcement Natalizumab (Tysabri) - A to Z of MS PML (progressive multifocal leukoencephalopathy) - A to Z of MS (Source: Multiple Sclerosis Trust)

J&J to pay $158 million to settle Texas Risperdal case

Reuters: Health — Thu, 19 Jan 2012 17:43:16 +0100

AUSTIN, Texas (Reuters) - Johnson & Johnson said on Thursday it will pay $158 million to settle a Texas lawsuit accusing the drugmaker of improperly marketing its Risperdal anti-psychotic drug to state residents on the Medicaid health program for the poor. (Source: Reuters: Health)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Are medical communities the new marketing demographic?

Thrive, Children's Hospital Boston — Thu, 19 Jan 2012 13:48:19 +0100

Have you heard about the bald Barbie movement? It’s a grassroots, digital campaign asking Mattel to make a version of the doll without her trademark golden locks to benefit children with illness. According to the group’s Facebook page, which has gained more than 130,000 fans in less than a month, bald Barbie would let “children suffering cancer, alopecia and any other illness that causes them to lose their hair, feel just as beautiful as the dolls they play with.” Regardless of how people feel about the plastic fashion icon—she’s been around for more than half a century but still seems to be a very polarizing figure; often because of her figure—the online support for bald Barbie is undeniable. Many people seem ready to overlook any issues they may have had...

Pharma’s mobile opportunity: Adherence, marketing, trials

mobihealthnews — Thu, 19 Jan 2012 11:55:22 +0100

In recent months a number of deals, acquisitions, service and product launches have led to a growing discussion around the mobile health opportunities for pharma companies. There seem to be three big ones vying for the top. Is it adding connectivity to clinical trials? Earlier this month research analyst firm Cutting Edge Information (CEI) published a report [...] (Source: mobihealthnews)

Presently available biosimilars in hematology-oncology: G-CSF

Targeted Oncology — Thu, 19 Jan 2012 06:56:41 +0100

Abstract Biopharmaceuticals were copies of endogenous human proteins developed in the mid-1990s that were characterized by complex three-dimensional, high-molecular weight compounds. What made them unique was that contrary to classical chemotherapeutical drugs, they were manufactured by living cells. One of these biopharmaceuticals was granulocyte-colony stimulating factor (G-CSF). Once their patent expired, generic versions appeared in pharmacies. They are now called biosimilars. There are several biosimilar G-CSFs approved in Europe: Biograstim®/Filgrastim ratiopharm/Ratiograstim®/Tevagrastim® (XM02); Zarzio® and Nivestim®. All these new products are manufactured in facilities with state-of-the-art technology. All products have passed the regulatory requirements for...

The role of disease characteristics in the ethical debate on personal genome testing

BMC Medical Genomics — Thu, 19 Jan 2012 05:00:00 +0100

DiscussionIn this paper, we identify and discuss four disease characteristics - severity, actionability, age of onset, and the somatic/psychiatric nature of disease - and show how these lead to specific ethical issues. By way of illustration, we apply this framework to genetic susceptibility testing for three diseases: type 2 diabetes, age-related macular degeneration and clinical depression. For these three diseases, we point out the ethical issues that are relevant to the question whether it is morally justifiable to offer genetic susceptibility testing to adults or to children or minors, and on what conditions.SummaryWe conclude that the ethical evaluation of personal genome tests is challenging, for the ethical issues differ with the diseases tested for. An understanding of the ethical...

Social media analytics for radical opinion mining in hate group web forums - Yang M, Kiang M, Ku Y, Chiu C, Li Y.

SafetyLit: All (Unduplicated) — Wed, 18 Jan 2012 13:13:29 +0100

Web forums are frequently used as platforms for the exchange of information and opinions as well as propaganda dissemination. But online content can be misused when the information being distributed, such as radical opinions, is unsolicited or inappropriat... (Source: SafetyLit: All (Unduplicated))

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Budco and Ford Motor Company to Appear as Featured Speakers at PODi...

PRWeb: Medical Pharmaceuticals — Wed, 18 Jan 2012 06:54:11 +0100

Budco, a leading fulfillment and direct marketing organization, and Ford Motor Company will share insight about multichannel communications at the tenth annual PODi AppForum, an industry-leading...(PRWeb January 17, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9107278.htm (Source: PRWeb: Medical Pharmaceuticals)

Cytomedix Appoints Cathryn Hope as Vice President of Marketing

HSMN NewsFeed — Wed, 18 Jan 2012 01:14:34 +0100

GAITHERSBURG, MD--(Healthcare Sales & Marketing Network)- Cytomedix, Inc. (OTC.BB: CMXI.OB ) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced the app... Regenerative Medicine, PersonnelCytomedix (Source: HSMN NewsFeed)

Manta Rays Endangered by Sudden Demand from Chinese Medicine

Scientific American - Official RSS Feed — Tue, 17 Jan 2012 21:20:00 +0100

Demand for the gills of manta and mobula rays has risen dramatically in the past 10 years for use in traditional Chinese medicine (TCM), even though they were not historically used for this purpose, a team of researchers from the conservation organizations Shark Savers and WildAid has discovered.“We first came across manta and mobula ray gills in Asian markets several years ago, and followed the trail to the dried seafood markets of southern China,” Manta Ray of Hope Project lead investigator Paul Hilton said in a prepared statement ( pdf ) released on January 14. Specifically, the market was for gill rakers, the thin filaments that manta and mobula rays use to filter food from the water, which are being sold for up to $500 per kilogram. TCM practitioners are marketing the rake...

Colony stimulating factors (CSF) biosimilars. Progress?

Targeted Oncology — Tue, 17 Jan 2012 07:16:01 +0100

Abstract Biosimilars are equivalent drugs for other biotechnological drugs for which patent has expired. These biopharmaceuticals are often looked upon as simple copies of parent drugs whose goal is solely to potentially generate costs savings. The expansion of available drugs is a subject of attention, criticism and quarrels, often related to a lack of product knowledge. These drugs are copies but need scientific development that must meet many strict rules. Many questions arise in connection with the marketing of several biosimilar drugs in the field of hematopoietic growth factors of white and red cells. Many of them should be discussed. Content Type Journal ArticleCategory ReviewPages 1-8DOI 10.1007/s11523-011-0189-2Authors Florian Scotté, European Hospital Geor...

Pro athletes bolster star status through team selection, teammates and career evolution: Study

EurekAlert! - Social and Behavioral Science — Tue, 17 Jan 2012 05:00:00 +0100

(University of Toronto, Rotman School of Management) Basketball fans in Cleveland may disagree, but two-time NBA Most Valuable Player Lebron James' decision to play with a higher-profile Miami Heat team and all-star teammates shows sound marketing and career-management acumen, according to newly published business school research focused on the evolution and importance of star status for today's professional athletes. In order to maximize their earnings and endorsements, today's celebrity athletes need to be mindful of the evolution of their star status. (Source: EurekAlert! - Social and Behavioral Science)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Hope for the Future: Identifying the Individual Difference Characteristics of People Who Are Interested In and Intend To Foster-Care

British Journal of Social Work — Tue, 17 Jan 2012 05:00:00 +0100

High-quality foster placements can help a foster-child to thrive and can counter some of the risk factors normally associated with being a foster-child. Unfortunately, demand for foster-carers has been outstripping supply. The present study sought to identify the characteristics of people who have high potential to become a foster-carer. A large, representative sample from the general population (544 male; 544 female; Mage = 40.8; SD = 13) completed an anonymous survey that included comprehensive measurement of demographics, personal resources (e.g. social support), personal characteristics (e.g. hope) and foster-care interest, intentions and information seeking. Analyses revealed that people who sought information about and expressed interest/intention towards foster-caring where those wh...

PCR Detection and Identification of Histamine‐Forming Bacteria in Filleted Tuna Fish Samples

Journal of Food Science — Tue, 17 Jan 2012 05:00:00 +0100

In this study, we used a molecular approach for the detection of histamine‐forming bacteria in fish. PCR‐based methods require expensive equipment and a high degree of training for the user, but are fast (< 24 h) and reliable. They now represent the best predictive methods to identify a potential risk factor in fish products during processing, storage, and marketing and can be used in the investigation of risk reduction strategies. (Source: Journal of Food Science)

The Research Works Act

Libraries in the NHS — Sun, 15 Jan 2012 05:00:00 +0100

My experience of negotiating with publishers is that they find it difficult to quantify or even identify the value they believe they add to the outputs of publicly funded research. I don't want to be too specific about the publisher. I don't think it matters who they were, although it wasn't Elsevier.About ten years ago we were negotiating the terms and conditions for the renewal of a large contract involving publicly funded research outputs. We were trying to reach fair price essentially, somewhere on a continuum between £0 and £several million per annum. Difficult. At one point we wrote to the publisher asking two questions:How were they going to take account of the financial contribution from the public sector into the production of the research, which we estimated conservativel...

Premier Faculty to Congregate at 2012 DTC National Conference for...

PRWeb: Medical Pharmaceuticals — Sat, 14 Jan 2012 17:41:50 +0100

Speakers Include Political Experts, Industry Leaders and Marketing Gurus(PRWeb January 13, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9096956.htm (Source: PRWeb: Medical Pharmaceuticals)

Health 2.0 Marketing Good Medicine for Doctors and Patients Who Go...

PRWeb: Medical Pharmaceuticals — Sat, 14 Jan 2012 17:41:50 +0100

According to CardioChoices.com, cardiologists and other medical doctors will do well this year marketing on medical sites, as patients—particularly seniors—increasingly turn to the Internet to...(PRWeb January 10, 2012)Read the full story at http://www.prweb.com/releases/-cardiac-care-websites-/-health20marketing-/prweb9093542.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Ad men use brain scanners to probe our emotional response

Guardian Unlimited Science — Sat, 14 Jan 2012 17:28:08 +0100

Neuromarketers are using MRI scanners and electrode caps to work out our hidden reactions to their advertsThe world's biggest companies have got a new way of convincing you to buy their products – by getting inside your head. Brands including Google, Facebook and ITV are turning to mind-reading technology to help them develop products and create adverts that people like.Traditionally, focus groups have been used to tell marketeers what they think of adverts. Unfortunately for advertisers, some people don't tell the truth.Faced with the prospect of consumers hiding their emotions – perhaps a middle-aged man reluctant to reveal that he shed a tear at a sentimental John Lewis Christmas advert – a new breed of "neuromarketer" has emerged, armed with medical technology to probe consumers'...

Plaintiffs, Defendants Argue Where To Consolidate Flea Treatment Efficacy Suits

LexisNexis® Mealey's™ Emerging Toxic Torts Legal News — Sat, 14 Jan 2012 10:16:58 +0100

MIAMI - When the U.S. Judicial Panel on Multidistrict Litigation sits in hearing session on Jan. 26 in Miami, among the oral arguments it will hear is a dispute over where to consolidate products liability litigation in which the plaintiffs allege injuries to pets from ineffective topical flea treatments; the hearing sessions order was filed Dec. 21 (In re: Bayer Healthcare and Merial Limited Flea Control Products Marketing & Sales Litigation, MDL 2319, JPMDL). Full story on lexis.com (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)

Marketing transitions for Transitions Optical

Modern Medicine — Sat, 14 Jan 2012 09:48:18 +0100

Transitions Optical has centralized its multicultural marketing efforts under one initiative, called Transitions Cultural Connections. Through the program, Transitions Optical aims to raise awareness among culturally diverse groups about the importance of getting regular eye exams and wearing the right corrective eyewear. To continue to drive the brand’s growth, the company recently appointed Sherianne James as director of North America Marketing. (Source: Modern Medicine)

Biosimilars: Current perspectives and future implications

Indian Journal of Pharmacology — Sat, 14 Jan 2012 05:00:00 +0100

This article will address the differences between biosimilars and chemical generics, issues of concern with the use of biosimilars and need of appropriate regulations for their approval. (Source: Indian Journal of Pharmacology)

PIP breast implants – latest from the NHS

NHS News Feed — Fri, 13 Jan 2012 22:00:00 +0100

Women concerned about French-made PIP breast implants can find all the latest NHS information about the issue on this page. Worries about the implants have emerged since news of a major investigation into them in France was widely covered in the media in December 2011. It is thought that around 40,000 women in the UK have the implants, with about 95% of them having been provided privately for purely cosmetic reasons. What’s the problem? The French implants caused global concern after it was revealed they contained industrial silicone rather than medical-grade fillers and that they may be more prone to rupture and leakage. Initially reports also linked the implants to a rare form of cancer known as ALCL. This cancer link has been now been firmly discounted by medical experts here and i...

MedWorm Sponsor Message: Find the best January Sales in the UK.

SOPA - yeah, not a good idea

Scientific American - Official RSS Feed — Fri, 13 Jan 2012 17:38:00 +0100

Those of you who read my blogs may know I am a staunch supporter of intellectual property rights. A great many creative works exist because intellectual property laws allow people to spend time creating when they’d otherwise work non-creative jobs to pay the rent.The internet has, on balance, been a marketing boon for content creators, especially for small artists who previously could only access buyers through layers of intermediaries. But easy distribution has a down side. Parasites flourish in environments where content is copied so freely. International piracy is an especially tricky problem for content creators in developed countries, and some of the larger content owners have crafted this thing called SOPA in an attempt to fight back. In essence, SOPA allows content creators to...

EmpowHER Media launches new social media channels for marketing to women

Healthcare IT News Press Releases — Fri, 13 Jan 2012 14:04:46 +0100

EmpowHER, an award-winning social health company for women, today announces new social media properties focusing around the business of marketing to women, and the emergence of Health 3.0 -- the social health movement driven by peer health via social networking and health information sharing, and how marketers and healthcare executives can understand and capitalize on this new era. read more (Source: Healthcare IT News Press Releases)

EXTRA STRENGTH HEADACHE RELIEF (Acetaminophen, Aspirin And Caffeine) Tablet, Film Coated [CHAIN DRUG MARKETING ASSOCIATION INC]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Fri, 13 Jan 2012 05:00:00 +0100

Updated Date: Jan 13, 2012 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

'No Decision About Me, Without Me': A place for social marketing within the new Public Health architecture?

The Journal of the Royal Society for the Promotion of Health — Fri, 13 Jan 2012 05:00:00 +0100

July 2011 marked the 40th anniversary of social marketing. However, while the previous Labour administration dedicated sustained resources and support to developing the field of social marketing, this was followed by a time of uncertainty during the Coalition Government’s ascent to power. This paper explores the potential future position of social marketing within David Cameron’s evolving public health landscape, outlining areas of synergy between social marketing’s key features, and the coalition’s emergent public health architecture. The paper concludes with an exploration of the development opportunities nascent within social marketing, suggesting that support for the new commissioners (GP and local authority), and an enhanced emphasis on evaluation of financial ...

Questcor Pharmaceuticals Issues Statement

Drugs.com - Pharma News — Thu, 12 Jan 2012 14:01:06 +0100

ANAHEIM, Calif., Jan. 11, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced it became aware that an investor blog is preparing to issue a report regarding the Company's marketing and business practices.... (Source: Drugs.com - Pharma News)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Childhood Obesity in Developing Countries: Epidemiology, Determinants, and Prevention.

ENDOCR REV — Thu, 12 Jan 2012 05:00:00 +0100

Authors: Gupta N, Goel K, Shah P, Misra A Abstract Rapidly changing dietary practices and a sedentary lifestyle have led to increasing prevalence of childhood obesity (5-19 yr) in developing countries recently: 41.8% in Mexico, 22.1% in Brazil, 22.0% in India, and 19.3% in Argentina. Moreover, secular trends indicate increasing prevalence rates in these countries: 4.1 to 13.9% in Brazil during 1974-1997, 12.2 to 15.6% in Thailand during 1991-1993, and 9.8 to 11.7% in India during 2006-2009. Important determinants of childhood obesity include high socioeconomic status, residence in metropolitan cities, female gender, unawareness and false beliefs about nutrition, marketing by transnational food companies, increasing academic stress, and poor facilities for physical activity. Childho...

Competitive Technologies Announces Search for Medical Director to Focus on Calmare(R) Pain Therapy Medical Device

Medical News (via PRIMEZONE) — Wed, 11 Jan 2012 18:03:00 +0100

FAIRFIELD, Conn., Jan. 11, 2012 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (OTCQX:CTTC) has initiated a search for a medical director. In late 2011, the Company embarked on a focused marketing program targeting doctors and patients who would benefit from Calmare(r) Scrambler Therapy(tm) treatments. The program has been instrumental in increasing the number of medical practices using the Calmare device to treat patients with chronic neuropathic pain from maladies such as chemotherapy-induced peripheral neuropathy (CIPN), chronic cancer pain, failed back surgery syndrome (FBSS), sciatic and lumbar pain, phantom limb syndrome, post-herpetic neuralgia (PHN), post-surgical neuropathic pain, and brachial plexus neuropathy. Hiring a physician who has experience working with neuropathic pa...

Pressure BioSciences, Inc. Announces Global Co-Marketing/Selling and Instrument Co-Development Agreement With Digilab, Inc.

Medical News (via PRIMEZONE) — Wed, 11 Jan 2012 16:50:00 +0100

SOUTH EASTON, Mass., Jan. 11, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI") and Digilab, Inc. ("Digilab") (together "the companies") today announced that they have entered into a co-marketing/selling and research and development agreement. The companies intend to co-market and sell their respective product lines worldwide, including in industry publications, at scientific meetings, on each company's website, through common collaborator studies, at key industry trade shows, and in visits to customer sites. PBI and Digilab also intend to explore ways to co-develop new instrumentation, accessories/modules for existing instrumentation, and consumables that combine the robotics and high throughput capabilities of Digilab products with the extraction, protein digestio...

Canadians favor banning kid junk food ads

Health News - UPI.com — Wed, 11 Jan 2012 01:26:59 +0100

OTTAWA, Jan. 10 (UPI) -- Most Canadians say they strongly support banning marketing of high-fat, high-sugar or high-salt foods aimed at kids and youth, a survey indicates. (Source: Health News - UPI.com)

Desperate measures

Thrive, Children's Hospital Boston — Tue, 10 Jan 2012 13:16:31 +0100

Have you seen the anti-childhood obesity ads from Georgia? With 40% of the kids in Georgia overweight or obese (only Mississippi is worse), health advocates decided that it was time for “a wake-up call.” So the Strong4Life campaign and Children’s Healthcare of Atlanta have released print and TV ads with obese kids and slogans like “It’s hard to be a little girl when you’re not.” Ouch. I mean, really. Imagine being on a playground and having some kid point at you and say, “You look like the fat girl on TV!” What were they thinking? Actually, I get what they were thinking. It’s a desperate-times-call-for-desperate-measures thing. We do need a wake-up call. It’s not like Georgia is the only place with a childhood obesity problem. Nationwide, a third of US kids are o...

Mylan Confirms First-to-File Patent Challenge Relating to Actoplus Met XR Tablets

Drugs.com - Pharma News — Mon, 09 Jan 2012 13:01:21 +0100

Expects to qualify for 180 days of marketing exclusivity PITTSBURGH, Jan. 9, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that the company has been sued by Takeda Pharmaceutical Company, Watson Pharmaceuticals and Andrx Labs... (Source: Drugs.com - Pharma News)

MissionIR News - BioDelivery Sciences (BDSI) and Endo Pharmaceuticals...

PRWeb: Medical Pharmaceuticals — Mon, 09 Jan 2012 06:15:06 +0100

Endo Pharmaceuticals to be responsible for the manufacturing, distribution, marketing and sales of BEMA Buprenorphine on a worldwide basis.(PRWeb January 07, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9086568.htm (Source: PRWeb: Medical Pharmaceuticals)

FTC lawsuit targets acai berry marketing ads that pose as legitimate product reviews

NaturalNews.com — Mon, 09 Jan 2012 06:00:00 +0100

Earlier in the year, the Consumer Wellness Center (CWC) conducted an investigation into those tricky acai berry diet advertisements that lure web surfers into purchasing "free" or low-cost trials of weight loss supplements, only to have their credit cards charged for... (Source: NaturalNews.com)

Hansen Medical to Highlight Sensei(R) X Robotic Catheter System and Related Products at the Boston Atrial Fibrillation Symposium

HSMN NewsFeed — Fri, 06 Jan 2012 22:17:19 +0100

Company to Demonstrate Its Advanced Catheter Control With 3D Visualization, and Advanced Training Programs MOUNTAIN VIEW, CA--(Healthcare Sales & Marketing Network)- Hansen Medical, Inc. (NASDAQ: HNSN ), a global leader in flexible catheter robotics and... Devices, CardiologyHansen Medical, Sensei, Robotic Catheter System, Atrial Fibrillation (Source: HSMN NewsFeed)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

NHS PIP breast implants to be removed for free

NHS News Feed — Fri, 06 Jan 2012 18:47:00 +0100

There is not enough evidence to recommend the routine removal of PIP breast implants, a government expert committee has concluded. However, the committee said the NHS would remove and replace the implants without charge if patients it had operated on remained concerned. The government said it expected the private sector to follow suit and not to charge for corrective procedures. The French implants caused global concern after it was revealed they contained industrial silicone rather than medical-grade fillers and that they may be more prone to rupture and leakage. Some 40,000 women in the UK are believed to have had the implants, with 95% of operations done for cosmetic reasons through private clinics. The expert group recommended that any worried woman should speak to her surgeon or GP. N...

Segmenting and targeting american university students to promote responsible alcohol use: a case for applying social marketing principles. - Deshpande S, Rundle-Thiele S.

SafetyLit: All (Unduplicated) — Fri, 06 Jan 2012 15:21:09 +0100

The current study contributes to the social marketing literature in the American university binge-drinking context in three innovative ways. First, it profiles drinking segments by "values" and "expectancies" sought from behaviors. Second, the study compar... (Source: SafetyLit: All (Unduplicated))

China Kanghui Holdings Receives FDA Approvals for Hip and Knee Systems

HSMN NewsFeed — Fri, 06 Jan 2012 12:54:23 +0100

CHANGZHOU, China , Jan. 6, 2012 Healthcare Sales & Marketing Network -- China Kanghui Holdings (NYSE: KH ) ("Kanghui" or the "Company"), a leading domestic developer, manufacturer and marketer of orthopedic implants in China , today ann... Devices, Orthopaedic, FDAChina Kanghui Holdings, TGM Medical, Helicon Hip System, Milestone Knee System (Source: HSMN NewsFeed)

Horizon scanning: MHRA to review marketing authorisation application for lisdexamfetamine for ADHD

NeLM - Mental Health — Fri, 06 Jan 2012 05:00:00 +0100

Source: BioSpace Area: News According to BioSpace, the MHRA has accepted for review a marketing authorisation application for lisdexamfetamine dimesylate (Venvanse®), intended for use in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). The MHRA will act as the Reference Member State for this Decentralised Procedure, which will initially include eight European countries. Lisdexamfetamine is a long-acting (once-daily) prodrug of dextroamfetamine that is already approved in the US and Canada (brand name Vyvanase®). The current application follows the completion of a European Phase III study of Venvanse® in 336 children and adolescents (aged 6 to 17 years) with ADHD [no details of the study are included in the report]. (Source: NeLM - Mental Health)

Horizon scanning: Marketing authorisation application for ceftobiprole to be filed in the EU

NeLM - News — Fri, 06 Jan 2012 05:00:00 +0100

Source: BioSpace Area: News According to a BioSpace report, Basilea Pharmaceutica have announced that it will be filing an application for marketing authorisation of ceftobiprole in the EU for the treatment of severe pneumonia in the hospital setting in the second half of 2012. Please see the link below for further information. [Editor's note: A previous marketing authorisation application for this drug for a different indication - the treatment of complicated skin and soft tissue infections - was refused by the CHMP - please see the link below]. (Source: NeLM - News)

MedWorm Sponsor Message: Find the best January Sales in the UK.

J&J to pay more than $1 billion to settle probe: report

Reuters: Health — Thu, 05 Jan 2012 21:01:56 +0100

(Reuters) - Johnson & Johnson is set to pay more than $1 billion to resolve a U.S. civil investigation into the marketing of its Risperdal antipsychotic drug, Bloomberg News reported on Thursday, citing anonymous sources. (Source: Reuters: Health)

Drugs.com taps Healthline to monetize its 3.6M mobile users

mobihealthnews — Thu, 05 Jan 2012 16:31:46 +0100

Healthline Networks inked a deal with Drugs.com to become the exclusive provider of direct to consumer advertising for the popular site, which counted about 19.4 million unique visitors in the month of October. Drugs.com provides “free, independent, peer-reviewed, objective and up-to-date drug information” to both consumers and medical professionals. The deal is for consumer marketing [...] (Source: mobihealthnews)

Woman files class action lawsuit against Frito-Lay for marketing genetically-modified snacks as 'all natural'

NaturalNews.com — Thu, 05 Jan 2012 06:00:00 +0100

Many major food manufacturers have been on a kick to jump on the "all natural" bandwagon, with all sorts of processed food products now claiming to be healthy and free of artificial and synthetic ingredients. However, one such company, Frito-Lay, is the subject of a... (Source: NaturalNews.com)

Less than One Percent of Hospitals Fully use Tablet Devices

ICMCC: The International Council on Medical and Care Compunetics — Wed, 04 Jan 2012 13:38:30 +0100

Source: Justin Montgomery, Digital Marketing Blog Content: “Though tablet usage among healthcare providers remains a hot topic, it’s been revealed that less than 1 percent of hospitals currently have fully functional tablet systems in place as we enter the New Year. The low adoption numbers are despite aggressive financial incentives from the government and stem from [...] (Source: ICMCC: The International Council on Medical and Care Compunetics)

Zimbabwe: GMB Steps Up War Against HIV

AllAfrica News: HIV-Aids and STDs — Wed, 04 Jan 2012 07:34:01 +0100

The Herald (Harare)-THE Grain Marketing Board has re-committed itself in responding to HIV and Aids and has pledged to scale up its current workplace interventions as part of its contribution to an Aids-free generation. (Source: AllAfrica News: HIV-Aids and STDs)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Welch Allyn wins communications awards

Modern Medicine — Wed, 04 Jan 2012 05:00:00 +0100

Welch Allyn has received four MarCom Awards from the Association of Marketing and Communication Professionals. (Source: Modern Medicine)

Guidelines on the safety of light‐based home‐use hair removal devices from the European Society for Laser Dermatology

Journal of the European Academy of Dermatology and Venereology — Tue, 03 Jan 2012 05:00:00 +0100

AbstractIn the past 5 years since their US introduction, there has been a rapid proliferation of light‐based hair removal devices intended for home‐use. In the last 2 years in Europe, sales already run into many tens of thousands of units with well‐known multi‐national companies entering the market. These guidelines provide a definition of light‐based home‐use technology, to inform healthcare professionals about home‐use light‐based technology and encourage manufacturers wishing to sell in Europe to adopt ‘best practice’. The review presents the current status on standards and regulation issues and considers home‐use safety issues, encompassing human, device and electrical safety, given risks to the eyes and skin from optical radiation both to the consumer and per...

Galvus 50 mg Tablets (vildagliptin)- Revised SPC

NeLM - SPC Changes — Tue, 03 Jan 2012 05:00:00 +0100

Source: eMC (electronic Medicines Compendium) Area: Other Library Updates > SPC Changes There have been significant updates to several sections of the SPC, including the following: Change to section 4.2 - Posology and method of administration No dose adjustment is required in patients with mild renal impairment (creatinine clearance ? 50 ml/min). In patients with moderate or severe renal impairment or with end-stage renal disease (ESRD), the recommended dose of Galvus is 50 mg once daily (see also sections 4.4, 5.1 and 5.2). Change to section 4.8 - Undesirable Effects Changes to post marketing experience regarding case of abnormal liver tests and cases of hepatitis. During post-marketing expe...

Obesity and Public Policy.

Annual Review of Clinical Psychology — Tue, 03 Jan 2012 05:00:00 +0100

Authors: Gearhardt AN, Bragg MA, Pearl RL, Schvey NA, Roberto CA, Brownell KD Abstract There is a pressing need to reduce both the prevalence and impact of obesity. This review begins with a discussion of the roles of treatment and prevention. Two overriding issues, weight bias and the addictive nature of food, are covered because of their importance not only to the individuals affected but also to public policy. We then cover promising policy areas in which changes can be implemented to support healthy behaviors: school policy, food marketing, food labeling and packaging, and taxes on unhealthy foods. The roles of the food industry and federal, state, and local governments are also discussed. Expected final online publication date for the Annual Review of Clinical Psychology Volu...

The Intersection of Nursing and Marketing: Keys to Success for This Unique Assisted Living Challenge

Geriatric Nursing — Tue, 03 Jan 2012 05:00:00 +0100

There are approximately 1,000,000 residents living in more than 38,000 assisted living communities across the nation. An overwhelming majority (as high as 90%) of those residents are using private funds to pay for assisted living, with some receiving assisted living services through Medicaid waiver programs. This emphasis on private pay contributes to a consumer-driven model of care, but it also places increased significance on the role of marketing and sales activities. While recognizing the value of the consumer-driven nature of the industry, it is also important to recognize the need for marketing and nursing staff to work collaboratively to ensure that a particular assisted living community/provider is able to deliver on the care and services that are promised during the sales process....

MedWorm Sponsor Message: Find the best January Sales in the UK.

Reply to the comment re: "Traumatic brain injuries in illustrated literature: experience from a series of over 700 head injuries in the Asterix comic books" by Nikolas Lloyd. - Kamp MA, Slotty P, Sarikaya-Seiwert S, Steiger HJ, Hänggi D.

SafetyLit: All (Unduplicated) — Sun, 01 Jan 2012 12:07:07 +0100

[Abstract unavailable] Language: Eng... (Source: SafetyLit: All (Unduplicated))

Surfing for mouth guards: assessing quality of online information. - Magunacelaya MB, Glendor U.

SafetyLit: All (Unduplicated) — Sun, 01 Jan 2012 12:07:07 +0100

Abstract - Introduction: The Internet is an easily accessible and commonly used source of health-related information, but evaluations of the quality of this information within the dental trauma field are still lacking. Aim: The aims of this study ... (Source: SafetyLit: All (Unduplicated))

Positioning Patient-Perceived Medical Services to Develop a Marketing Strategy

The Health Care Manager — Sun, 01 Jan 2012 06:00:00 +0100

In today’s medical market, marketing philosophy is being rapidly transformed from customer searching to patient satisfaction and service improvement. The principal objective of this study was to contribute to the establishment of a desirable medical marketing strategy, through the factors of customer satisfaction and the positioning of patients’ perceptions by marketing institutions. The data were collected from 282 students of the College of Public Health and Medicine in Seoul. The survey tools were developed using the SERVQUAL scale. Analysis in this study involved both statistical and network analysis. The former was used to verify the determinants of service satisfaction as perceived by respondents, via factor analysis and multiple regression analysis. The latter was obtained using...

The Intra‐ and Inter‐Personal Dynamics Associated with Consuming Sensitive Products: Understanding the Consumption of Erectile Function Aids Using Dimensional Qualitative Research

Psychology and Marketing — Sun, 01 Jan 2012 05:00:00 +0100

This study utilizes a dimensional qualitative research (DQR) approach to examine what men think, feel, and experience as they consider integrating erectile function (EF) aids into their sexual relationships. The findings suggest that the process of accepting changes in sexual functioning and consuming EF aids frequently moves beyond intrapersonal issues to encompass spouse/partner relationships. The insights gleaned from this study have implications not only for the marketing of EF aids but also for healthcare professionals assisting men in the treatment of their symptoms. Finally, the study findings expand current marketing applications of the DQR framework by demonstrating the value of second‐order modality analysis. (Source: Psychology and Marketing)

When Satisfied Consumers Do Not Return: Variety Seeking's Effect on Short‐ and Long‐Term Intentions

Psychology and Marketing — Sun, 01 Jan 2012 05:00:00 +0100

ABSTRACTEven satisfied consumers frequently do not come back, which challenges loyalty theory and marketing practice. It is reasoned that variety‐seeking tendencies will significantly affect short‐term revisit intentions, whereas satisfaction and regret will mostly determine long‐term revisit intentions. Thus, the influence of satisfaction on loyalty is hypothesized to be critically dependent on the time perspective of the intentions, now or later, and variety seeking. A representative survey (N = 400) in eight Spanish cities supported these predictions. Multivariate moderated‐mediation analyses revealed that indeed the influence of satisfaction, regret, and variety seeking critically depends on the time perspective of the behavioral intentions. (Source: Psychology and Marketing)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Consumer Intentions to Revisit Online Retailers: A Mental Imagery Account

Psychology and Marketing — Sun, 01 Jan 2012 05:00:00 +0100

ABSTRACTThe current research explores the role of Web site characteristics, such as animation and iconic navigation aids, in predicting consumers’ self‐reported intentions to revisit a retailer's Web site. An experimental study (n = 339) shows that Web site characteristics do not affect revisit intentions directly but through the vividness of mental images that consumers hold of the Web site as a whole. Vivid mental Web site imagery is stimulated by animation and facilitated by individual tendencies to put faith in intuitive rather than rational thinking, while it does not relate to the use of icons in navigation. The implications of these findings for researchers, Web designers and marketers are discussed. (Source: Psychology and Marketing)

The Eyes Have It: How a Car's Face Influences Consumer Categorization and Evaluation of Product Line Extensions

Psychology and Marketing — Sun, 01 Jan 2012 05:00:00 +0100

ABSTRACTThis research focuses on a previously unexamined risk associated with the widely used new product development strategy of line extensions. Specifically, it explores consumer reactions when line extensions become too visually similar and examines both short‐term and longer term strategies for solving the problem. Examined in the context of consumer durables, specifically, automobiles, the results show that consumers who make categorization mistakes when trying to distinguish between two visually similar product lines have more negative attitudes not only toward the product but also toward the parent brand. The results of Study 1 confirm that providing a design vocabulary that articulates the car's design features is effective in reducing consumer's categorization mistakes. In addi...

Groundswell – Winning in a World Transformed by Social Technologies. Charlene Li and Josh Bernoff, Harvard Business Press, 2009. ISBN‐13: 978‐1422125007

Psychology and Marketing — Sun, 01 Jan 2012 05:00:00 +0100

(Source: Psychology and Marketing)

Feds Tweak Medical-Loss Ratio Requirements: Health plans must inform members what fraction of premium dollars goes to medical care.

Clinical Neurology News — Sun, 01 Jan 2012 05:00:00 +0100

Federal officials are requiring health plans to give consumers more information about how they are spending their premium dollars. In a final rule, the Health and Human Services department made changes to its existing regulations governing health plans' medical-loss ratio (MLR). Under the Affordable Care Act, health plans must spend at least 80% of their premium dollars on medical care and quality improvement activities. For large group plans, the threshold is 85%. If plans spend more than the allowed amount on other costs, such as overhead and marketing, they must provide rebates to consumers. (Source: Clinical Neurology News)

(Re)Building an Image for a City: Is A Landmark Enough? Bilbao and the Guggenheim Museum, 10 Years Together1

Journal of Applied Social Psychology — Sun, 01 Jan 2012 05:00:00 +0100

The new global economic scenario has driven cities to urban entrepreneurialism and to a holistic marketing approach to define and manage successful redevelopment projects. Positioning in the chosen target market requires an image and a brand to communicate the city values, the assets that make her unique and better than her competitors. Urban design based on iconic buildings is one of the models of the culture‐led regeneration programs that are being developed to re‐image the city, to make her an attractive tourist destination. The present study analyzed the image and perception of Bilbao 10 years after the opening of the Guggenheim Museum, and concluded that more than the spectacular landmark should be considered to create a new image. (Source: Journal of Applied Social Psychology)

MedWorm Sponsor Message: Find the best January Sales in the UK.

The role of partnerships in promoting physical activity: the experience of Agita São Paulo.

Health and Place — Sun, 01 Jan 2012 05:00:00 +0100

Authors: Matsudo V Abstract Strategic partnership is a logical approach to face some of the public health problems. However, its application is somewhat more complex. In this paper our experience with three networks (Agita São Paulo, Physical Activity Network of Americas, and Agita Mundo Network) was described. In the case of Agita São Paulo even the name was a consequence of a partnership with a marketing company, and is an idiomatic expression that means much more than just to move your body. It also means to move psychologically and socially, with the concept of "active citizenship". Among the important features of that intervention, we highlighted: (a) national and international intellectual partnership; (b) strong institutional partnerships, including government in one hand,...

New Year’s Resolutions, Recycled, Are a Boon for Business

NYT Health — Sat, 31 Dec 2011 20:49:13 +0100

The self-improvement industry thrives on New Year’s resolutions gone awry. After all, if you don’t lose those pounds or stop smoking this year, you’ll probably try again in 2013. (Source: NYT Health)

Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Surgical Endoscopy and Video Equipment

HSMN NewsFeed — Fri, 30 Dec 2011 13:51:28 +0100

CHARLOTTE, N.C.--(Healthcare Sales & Marketing Network)-- The Premier healthcare alliance today announced new agreements for surgical endoscopy and video equipment have been awarded to Olympus America, Inc. and Gyrus ACMI, LP of Center Valley, Pa.; and Str... Devices, Group PurchasingPremier Purchasing, Olympus America, Gyrus ACMI, Stryker (Source: HSMN NewsFeed)

Florida Hospital Cancer Institute taps Ed Gilbert as chair

bizjournals.com Health Care:Hospitals headlines — Thu, 29 Dec 2011 19:10:24 +0100

Florida Hospital Cancer Institute tapped Ed Gilbert as 2012 chairman of the board, the hospital announced Dec. 29. Gilbert is CEO of Lake Mary-based Absolute Thinking Inc. a marketing company specializing in hospitality, real estate and retail. Click here for more information about Florida Hospital Cancer Institute. (Source: bizjournals.com Health Care:Hospitals headlines)

Mobile Devices and Meetings

Psychology Today Work Center — Thu, 29 Dec 2011 17:23:30 +0100

A few weeks ago, I was off site at a small biz client's office facilitating a marketing strategy session. At the start, everyone in the room was constantly checking their cell phones for email messages, texting and attempting to be both in the meeting and working— at the same time. Primary Topic: Work read more (Source: Psychology Today Work Center)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

MindFrame Inc Announces CE Mark for New Capture(TM) LP Devices for Treatment of Patients Experiencing Ischemic Stroke

HSMN NewsFeed — Thu, 29 Dec 2011 15:14:52 +0100

First and Only 4-mm Thrombectomy Devices That Can Be Deployed Through Catheters as Small as 10/14 Offer Improved Navigation and Aspiration IRVINE, Calif.--(Healthcare Sales & Marketing Network)-- MindFrame, Inc. today announces that a CE mark was grante... Devices, Interventional, RegulatoryMindFrame, Capture LP, thrombectomy (Source: HSMN NewsFeed)

Bayer’s Xarelto® (Rivaroxaban) Submitted for U.S. Marketing Authorisation to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome

Bayer Company News — Thu, 29 Dec 2011 13:00:00 +0100

(Source: Bayer Company News)

Gentium Provides Update on MAA Process for Defibrotide in Europe

HSMN NewsFeed — Thu, 29 Dec 2011 12:47:09 +0100

VILLA GUARDIA, Italy, Dec. 29, 2011 --(HSMN NewsFeed) -- Gentium S.p.A. (Nasdaq:GENT ) (the "Company") today provided an update on the European Marketing Authorization Application for Defibrotide (the "MAA") to treat and prevent hepatic... Biopharmaceuticals, RegulatoryGentium, Defibrotide, veno-occlusive disease (Source: HSMN NewsFeed)